Pradeep Shrestha

498 total citations
15 papers, 390 citations indexed

About

Pradeep Shrestha is a scholar working on Surgery, Immunology and Genetics. According to data from OpenAlex, Pradeep Shrestha has authored 15 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Pradeep Shrestha's work include Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (4 papers) and Phagocytosis and Immune Regulation (4 papers). Pradeep Shrestha is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (4 papers) and Phagocytosis and Immune Regulation (4 papers). Pradeep Shrestha collaborates with scholars based in United States, Nepal and United Kingdom. Pradeep Shrestha's co-authors include Esma S. Yolcu, Haval Shirwan, Min Tan, Hong Zhao, Kyle B. Woodward, Eugenie S. Kleinerman, Anchit Bhagat, Andrés J. Garcı́a, María M. Coronel and William S. Bowen and has published in prestigious journals such as Nature Materials, ACS Nano and The Journal of Immunology.

In The Last Decade

Pradeep Shrestha

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pradeep Shrestha United States 8 160 136 93 78 60 15 390
Lingxiao Zhang China 8 89 0.6× 359 2.6× 93 1.0× 99 1.3× 61 1.0× 15 595
Asako Tajima United States 12 57 0.4× 158 1.2× 45 0.5× 74 0.9× 75 1.3× 18 450
Anton Preisinger United States 7 116 0.7× 127 0.9× 70 0.8× 122 1.6× 42 0.7× 8 391
Jianing Hou China 11 35 0.2× 184 1.4× 50 0.5× 19 0.2× 50 0.8× 25 395
Han Zhu China 13 77 0.5× 276 2.0× 36 0.4× 22 0.3× 19 0.3× 23 409
Kyle B. Woodward United States 7 209 1.3× 59 0.4× 134 1.4× 86 1.1× 86 1.4× 14 334
Germaine D. Agollah United States 11 84 0.5× 232 1.7× 41 0.4× 12 0.2× 151 2.5× 22 630
Mona Malek Mohammadi Germany 9 78 0.5× 215 1.6× 19 0.2× 36 0.5× 12 0.2× 14 348
Charlotte E. Severn United Kingdom 8 48 0.3× 136 1.0× 21 0.2× 86 1.1× 18 0.3× 10 374

Countries citing papers authored by Pradeep Shrestha

Since Specialization
Citations

This map shows the geographic impact of Pradeep Shrestha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pradeep Shrestha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pradeep Shrestha more than expected).

Fields of papers citing papers by Pradeep Shrestha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pradeep Shrestha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pradeep Shrestha. The network helps show where Pradeep Shrestha may publish in the future.

Co-authorship network of co-authors of Pradeep Shrestha

This figure shows the co-authorship network connecting the top 25 collaborators of Pradeep Shrestha. A scholar is included among the top collaborators of Pradeep Shrestha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pradeep Shrestha. Pradeep Shrestha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shrestha, Pradeep, Rejeena Shrestha, You Zhou, et al.. (2025). STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis. Frontiers in Immunology. 16. 1608375–1608375. 2 indexed citations
2.
Shrestha, Pradeep, Lalit Batra, Zhengda Sun, et al.. (2023). Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease. Blood Advances. 7(10). 2181–2195. 2 indexed citations
3.
Bhagat, Anchit, Pradeep Shrestha, Prince Jeyabal, et al.. (2022). Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase. Frontiers in Oncology. 12. 947604–947604. 16 indexed citations
4.
Bhagat, Anchit, Pradeep Shrestha, & Eugenie S. Kleinerman. (2022). The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity. International Journal of Molecular Sciences. 23(23). 14649–14649. 36 indexed citations
5.
Shrestha, Pradeep, Lalit Batra, Mohammad Tariq Malik, et al.. (2020). Immune checkpoint CD47 molecule engineered islets mitigate instant blood-mediated inflammatory reaction and show improved engraftment following intraportal transplantation. American Journal of Transplantation. 20(10). 2703–2714. 20 indexed citations
6.
Batra, Lalit, Pradeep Shrestha, Hong Zhao, et al.. (2020). Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression. The Journal of Immunology. 204(10). 2840–2851. 37 indexed citations
7.
Barsoumian, Hampartsoum B., Lalit Batra, Pradeep Shrestha, et al.. (2019). A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells. Cancer Research. 79(4). 783–794. 14 indexed citations
8.
Woodward, Kyle B., Hong Zhao, Pradeep Shrestha, et al.. (2019). Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege. American Journal of Transplantation. 20(5). 1285–1295. 25 indexed citations
9.
Yerneni, Saigopalakrishna S., Sushil Lathwal, Pradeep Shrestha, et al.. (2019). Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers. ACS Nano. 13(9). 10555–10565. 93 indexed citations
10.
Headen, Devon M., Kyle B. Woodward, María M. Coronel, et al.. (2018). Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance. Nature Materials. 17(8). 732–739. 138 indexed citations
11.
Shrestha, Pradeep, William S. Bowen, Lalit Batra, et al.. (2018). CD47 Overcomes Early Loss of Pancreatic Islet Grafts Transplanted Intraportally. Transplantation. 102(Supplement 7). S47–S47. 1 indexed citations
12.
Shirwan, Haval, Kyle B. Woodward, Devon M. Headen, et al.. (2018). SA-FasL-engineered PEG microgels as a novel means of modulating immune response to allogeneic islet grafts. The Journal of Immunology. 200(Supplement_1). 55.36–55.36. 2 indexed citations
13.
Batra, Lalit, Pradeep Shrestha, Esma S. Yolcu, et al.. (2018). The Transient Display of a Chimeric PD-L1 Protein on Pancreatic Islets Promotes Indefinite Survival in Allogeneic Recipients. Transplantation. 102(Supplement 7). S455–S455. 2 indexed citations
14.
Shrestha, Pradeep, et al.. (2014). Association between Helicobacter Pylori and Gastric Cancer. Journal of Nepal Medical Association. 52(194). 757–763. 1 indexed citations
15.
Giri, Smith, et al.. (2012). A Case of Precocious Puberty in a Setting with Limited Resources. Kathmandu University Medical Journal. 9(4). 315–317. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026